Treatment for Bacterial Vaginosis (BV), a case of vaginal microbiome imbalance (dysbiosis) in women, have been limited to antibiotics, which are ineffective against BV recurrence. However, some physicians are beginning to advocate for probiotics to help restore eubiosis in the vaginal microbiome. One promising treatment, Lactin-V, a strain of Lactobacillus crispatus, has been studied as a suppository probiotic, showing promising results thus far. This review will discuss why supplemental Lactobacillus probiotics, with its natural protection and H2O2 production, should be integrated into the standard treatment of antibiotics for women with recurrent BV to combat its negative health impacts.